 |
On August 18, Fischell Institute for Biomedical Devices Director Bill Bentley (BIOE/IBBR), Professor Reza Ghodssi (ECE/ISR), and Bioengineering graduate student Eric VanArsdale spoke at the American Chemical Society’s (ACS) virtual annual meeting about the progress they have made in developing “smart marbles”— a novel way to control biologic signaling that allows cellular function to be modulated via a cell phone.
The life science industry news and information website BioSpace covered the ACS presentation in a feature story about the research.
These sensor devices, also known as “bPods” (bio-processing online devices), circulate in a bioreactor, measuring oxygen levels or detecting chemical signals and transmitting data via Bluetooth for batch optimization.
Possible applications include fast pathogen screens for biologics manufacturing, ingestible capsules to track blood sugar and – eventually – instruct other cells in the capsule to make insulin, and wearable devices to diagnose and treat bacterial infections.
Read the BioSpace story here.
—Thanks to our friends in the Robert E. Fischell Institute for Biomedical Devices, who reported this story in their August 29 Fischell Institute Brief.
Related Articles:
Rapidly evolving ‘smart marble’ sensors hold promise for monitoring pharmaceutical industry bioreactors and beyond
‘Smart Marbles’ hold promise for better outcomes from bioreactors
Chapin, Bowen win in Bioscience Day poster session
Adjustable Drug Release Marks New Milestone in Ingestible Capsule Research
Miao Yu to develop cost-effective sensor for measuring lake health
MSAL’s work on serotonin characterization and detection results in two journal covers
Abshire, Ernst receive MPower seed grant for using AI in understanding chronic pain biomarkers
Alum Timir Datta-Chaudhuri develops VNS biosensor for mice
Joshua Levy wins AVS Outstanding Paper Award
Zhao, Yu, Horiuchi propose gradient index acoustic metamaterial Luneburg lens
August 28, 2020
|
